Research ArticleClinical Studies

Determination of Optimal Dosage for Nedaplatin Based on Pharmacokinetic and Toxicodynamic Analysis

TORU ISHIBASHI, YOSHITAKA YANO and TAKAYOSHI OGUMA
Anticancer Research March 2005, 25 (2B) 1273-1281;

Article Information

vol. 25 no. 2B 1273-1281
PubMed 
15865078
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received July 26, 2004
  • Accepted December 29, 2004
  • Published online March 1, 2005.
Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. TORU ISHIBASHI,
  2. YOSHITAKA YANO and
  3. TAKAYOSHI OGUMA
  1. Developmental Research Laboratories, Shionogi and Co., Ltd., Osaka, Japan
  1. Correspondence to: Toru Ishibashi, 12-4-5, Sagisu, Fukushima-ku, Osaka 553-0002, Japan. Tel: +81-6-6455-2242, Fax: +81-6-6458-0987, e-mail: toru.ishibashi{at}shionogi.co.jp

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Determination of Optimal Dosage for Nedaplatin Based on Pharmacokinetic and Toxicodynamic Analysis
TORU ISHIBASHI, YOSHITAKA YANO, TAKAYOSHI OGUMA
Anticancer Research Mar 2005, 25 (2B) 1273-1281;
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section